CARLSON CAPITAL L P - LANTERN PHARMA INC ownership

LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 27 filers reported holding LANTERN PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CARLSON CAPITAL L P ownership history of LANTERN PHARMA INC
ValueSharesWeighting
Q3 2023$323,950
-39.5%
95,0000.0%0.02%
-45.7%
Q2 2023$535,800
-11.2%
95,000
-23.9%
0.05%
-19.3%
Q1 2023$603,267
-27.6%
124,900
-9.5%
0.06%
-10.9%
Q4 2022$833,520
+3.8%
138,000
-17.9%
0.06%
+4.9%
Q3 2022$803,000
-17.3%
168,000
-1.2%
0.06%
-9.0%
Q2 2022$971,000
-18.8%
170,000
+1.6%
0.07%
-18.3%
Q1 2022$1,196,000
+19.8%
167,300
+33.8%
0.08%
+43.9%
Q4 2021$998,000125,0000.06%
Other shareholders
LANTERN PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 365,930$1,721,0000.42%
CM Management, LLC 50,000$239,0000.27%
WOLFF WIESE MAGANA LLC 30,462$146,0000.12%
Redmond Asset Management, LLC 49,502$237,0000.09%
CARLSON CAPITAL L P 168,000$803,0000.06%
NewEdge Advisors, LLC 171,019$817,0000.01%
Sigma Planning Corp 17,500$84,0000.00%
WELLS FARGO & COMPANY/MN 3,984$19,0000.00%
NORTHERN TRUST CORP 12,629$60,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of LANTERN PHARMA INC shareholders